• Jinling Yu, Pingsheng Wang, Cui Nie, and Bo Zheng.
• Bayannur City Hospital, Inner Mongolia 015000, China.
• Medicine (Baltimore). 2021 May 7; 100 (18): e25556e25556.

BackgroundRheumatoid arthritis is a kind of chronic crippling disease, the condition is complex, the course of the disease is repeated, seriously affecting the quality of life of patients. Adverse reactions and drug resistance associated with conventional treatment can no longer meet the clinical need. Therefore, complementary and alternative therapies need to be explored. The evidence shows that silver needle therapy has advantages in the treatment of rheumatoid arthritis, but there is a lack of standard clinical studies to verify this conclusion.MethodsThis is a prospective randomized controlled trial to study the efficacy and safety of silver needles in the treatment of rheumatoid arthritis. Approved by the Clinical Research Ethics Committee of our hospital. The patients are randomly divided into a treatment group (silver needle treatment group) or control group (routine western medicine treatment group). The patients are followed up for 2 months after 4 weeks of treatment. Observation indicators include: TCM symptom score, HAQDI score, DAS-28 score, laboratory indicators, adverse reactions and so on. Data will be analyzed using the statistical software package SPSS version 18.0 (Chicago, IL).DiscussionThis study will evaluate the clinical efficacy of a silver needle in the treatment of rheumatoid arthritis. The results of this study will provide a reliable reference for the clinical use of a silver needle in the treatment of rheumatoid arthritis.Trial RegistrationOSF Registration number: DOI 10.17605/OSF.IO/4X5QB.Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

13 keywords...

hide…